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ATTITUDES TOWARD AND UPTAKE OF PRENATAL GENETIC SCREENING
AND TESTING IN TWIN PREGNANCIES
Kathryn M. Reese, BS
Advisory professor: Claire Singletary, MS
The rate of twinning is rising and is associated with delayed age at
childbirth and increased infertility treatments. Since the introduction of noninvasive prenatal testing, interest in and uptake of genetic screening and testing in
twin pregnancies has not been investigated. Therefore, this study aimed to describe
the attitudes toward and uptake of current prenatal genetic screening and testing
options in twin pregnancies. Forty-two women with twin gestations were recruited
from UTHealth and Baylor College of Medicine sites between August 2016 and
January 2017 for participation in a descriptive study consisting of a questionnaire
(n=42) and semi-structured phone interview (n=15). Descriptive statistics and
Fischer’s exact-test were employed for questionnaire analysis. Qualitative data
from interviews were analyzed using grounded-theory to identify common themes.
Data analysis showed that women were significantly more in favor of screening
than diagnostic testing (p = 0.049). Sixty-nine percent elected genetic screening,
while only three percent had a diagnostic procedure. Women were interested in
screening for preparation or reassurance despite having concerns about accuracy
and uncertainty associated with screening in twin pregnancies. Most women (86%)
felt they would make the same decision if it were a singleton pregnancy,
suggesting that twin pregnancy may not impact decision-making for many women.
Despite this, 48% of women still cited being pregnant with twins as an influencing
iii

factor. Information learned from medical providers, past experiences, and family
and friends were also cited as influencing factors, suggesting that tailoring
prenatal genetic counseling sessions for twin gestations might parallel that of
singletons. Although it did not alter patient decisions for 91% of women, genetic
counseling was used as a platform to raise concerns and gather information. No
significant differences between natural and assisted conception patients were
found; however, further research in this area is necessary given the small sample
size.
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INTRODUCTION
Genetic counselors may become involved in the prenatal care of women carrying twins
due to delayed childbirth and subsequent advanced maternal age (AMA) among other
indications. AMA is a common referral for prenatal genetic counseling and is defined as a
woman who will be 35 years or older at the time of delivery in a singleton pregnancy.
However, many clinicians use 31 or 33 years or older as AMA for twin pregnancies due to
the comparable risk for aneuploidy in at least one fetus (1).
According to data from the U.S. Department of Health and Human Services, the twin
birth rate was 33.9 per 1,000 births in 2014. This rate rose 76% from 1980 to 2009 and then
rose an additional two percent by 2013. Increasing twin birth rates have been associated with
trends of delayed age at childbirth and increased use and availability of infertility treatments
compared to previous decades (2). The American Society for Reproductive Medicine
(ASRM) defines assisted reproductive technology (ART) as treatments and procedures
involving the handling of human oocytes and sperm, or embryos, with the intent of
establishing pregnancy (3). ART has been used in the US since 1981 and today, 1% of all
infants born are conceived using ART. Women who undergo ART procedures are more
likely to have multiple gestations than women who conceive naturally.
The psychosocial impact of infertility and ART has been linked to distress, loss of
control, stigmatization, and a feeling of disruption in the way women viewed their life to go
(4). Some stressors experienced include infertility itself, inconvenience associated with
treatment, perception of a low success rate, time spent waiting for results, as well as financial
pressure (5).
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Whether conceived naturally or through ART, once women achieve a pregnancy, they are
faced with decisions about screening and testing. Genetic counselors often act as facilitators
for decision making about prenatal genetic screening, such as first trimester screen,
quadruple screen, or non invasive prenatal testing (NIPT) and diagnostic testing. This is
complicated in twin pregnancies because there is relatively little literature on aneuploidy
screening in twin pregnancies and conclusions are inconsistent. Detection rates for Down
syndrome when using first trimester nuchal translucency (NT) measurement and maternal
age are 70-88% in twin pregnancies, which is similar to that in singleton pregnancies (6). The
Down syndrome detection rate of a quadruple marker serum screen is 51-63% (7) compared
to 81% in singleton pregnancies (8). Diagnostic testing via chorionic villus sampling (CVS)
and amniocentesis is also available. The risks with CVS appear to be relatively comparable
between singletons and twins. However, the risk for miscarriage after amniocentesis appears
higher for twin gestations compared to singletons (9).
In 2011, NIPT became clinically available, providing more prenatal screening options for
high-risk pregnancies. NIPT using massively parallel shotgun sequencing (MPSS)
technology can be applied to twin gestations and screens for trisomy 21, trisomy 18, trisomy
13, and the presence of the Y chromosome. While detection rate varies by testing laboratory,
a meta-analysis in 2015 found a detection rate of 93.7% for trisomy 21 in twin pregnancies
and a false positive rate of 0.23% (10).
Prior to the availability of NIPT as a screening option, a studied cohort of 343 twin or
higher or multiple pregnancies and found a minority (23%) of patients elected to undergo
prenatal genetic screening or testing (11). The authors found that 94% of the patients who did
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have prenatal genetic screening or testing chose maternal serum screening. It was
hypothesized that it may be viewed as less risky than the alternatives while still relieving
some anxiety. Furthermore, no relationship was found between the use of ovulation induction
(OI) or ART and election of prenatal genetic testing (11, 12). However, these studies predate
NIPT, a screen with higher sensitivity and specificity. Therefore, this study aimed to describe
the uptake of and attitude toward current prenatal genetic screening and testing options in
twin pregnancies in order to provide insight into the factors that play a role in the choice to
undergo genetic screening or testing.
MATERIALS AND METHODS
Study Design
Women having genetic counseling at one of six McGovern Medical School at
UTHealth, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of
Maternal Fetal Medicine affiliated clinics or one of seven Baylor College of Medicine,
Department of Obstetrics and Gynecology affiliated high-risk pregnancy clinics were
recruited between August 2016 and January 2017. Eligible women included those who were
pregnant with twins, age 18 or older, and English speaking who were seen for prenatal
genetic counseling in their current pregnancy. Exclusion criteria included women under the
age of 18, singleton pregnancies, non-English speakers, and twin pregnancies seen in the
high-risk fetal center with anomalies excluded at the discretion of the genetic counselor.
Eligible women were given a letter of invitation by the genetic counselor at the
conclusion of the genetic counseling appointment. Participants could consent to either the
anonymous survey only or the anonymous survey and an additional phone interview. Semistructured interviews were conducted by the study coordinator (KR) via telephone with
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participants who indicated interest and provided contact information. Transcription by the
interviewer was performed by listening to recorded audiotapes and transcribing everything
spoken by the interviewer and study participant into a protected document.
The institutional review boards at the University of Texas Health Science Center at
Houston (HSC-MS-16-0410) and Baylor College of Medicine (H-39711) approved the study
protocol.
Data Collection
Data were collected through in person questionnaires collected immediately
following the genetic counseling appointment and via semi-structured telephone interviews
within eight weeks of the appointment. The survey collected information about attitudes
toward prenatal genetic screening and testing, changes related to the genetic counseling
appointment and impact of twin pregnancy on decision-making from participants.
Demographic information including age, gravidity and parity, indication for genetic
counseling, use of ART, genetic screening/testing offered, and genetic screening/testing
accepted was recorded by the genetic counselor (Appendix A). The telephone interviews
were conducted by the study coordinator (KR) using an interview guide (Appendix B) and
lasted approximately 20 minutes. The telephone interviews were audio taped and transcribed
by the interviewer. The study questionnaire and interview guide were created by the authors
and were not formally validated.
Data Analysis
Questionnaire data were entered into a secure Microsoft Excel file and STATA
software version 13.1 was used for statistical analysis of quantitative data. Categorical
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variable data were reported as frequencies and percentages and analyzed using two-sample ttest and Fischer’s exact test. Transcripts were entered into ATLAS.ti version 1.0.50.
Thematic analysis was used to identify major themes in the responses, using the grounded
theory approach. Each transcript was coded and grouped into categories that revealed similar
themes. The study coordinator (KR) and one author (CS) independently analyzed three
transcripts to compare and establish consistency in coding using a preliminary codebook. An
inter-coder concordance of 80% was achieved. KR analyzed the remaining transcripts and
grouped responses into themes.
RESULTS
A total of 42 individuals participated in the study. Of those, 27 (64%) consented to
participate in the phone interview in addition to the questionnaire, while 15 (36%) consented
to the questionnaire only. Of the 27 who indicated willingness to participate in the phone
interview portion, there were 16 (59%) individuals who completed the interview and 11
(41%) that could not be reached after multiple attempts. One completed interview was
excluded from analysis due to fragmented recording. The average age of study participants
was 31 years, with a range from 21 to 47 years old, and the majority were Caucasian (Table
I). The majority of participants were multigravida with the most common indications being
AMA (43%) and low risk (38%). Participants were recruited from Houston-area University
of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine
(Baylor) affiliated clinics. Eleven participants were from UTHealth clinics and 31 were from
Baylor clinics, representing 30% of eligible UTHealth patients (11/37) and 78% of eligible
Baylor patients (31/40) seen for prenatal genetic counseling during the survey collection
period. No significant differences in demographic distribution were found between
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participants from the UTHealth and Baylor sites (p > 0.05), (Table I). Additionally,
demographic distribution of the study sample was not significantly different between those
who were interviewed and those that only answered the questionnaire (p > 0.05), (Table I).
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Table I. Demographic characteristics of study participants (n=42)
Characteristic

Baylor**
(n=31)

UTHealth**
(n=11)

Interview &
Survey***
(n=15)

Survey
Only***
(n=27)

31.35

31.27

30.4

31.9

Mean Age (years)
Total SD = 5.6
n

%

n

%

n

%

n

%

Ethnicity
Caucasian
Hispanic
African American
Asian
Other

14
5
8
4
0

45%
26%
16%
13%
0%

5
3
1
1
1

46%
27%
9%
9%
9%

7
4
2
1
1

47%
27%
13%
7%
7%

12
4
7
4
0

44%
15%
26%
15%
0%

Indication
Low Risk
AMA
Positive Family History
US Abnormality
Multiple

11
12
1
3
4

35%
39%
3%
10%
13%

5
6
0
0
0

45%
55%
0%
0%
0%

8
5
0
1
1

53%
33%
0%
7%
7%

8
13
1
2
3

30%
48%
4%
7%
11%

Gravidity*
Primigravida
Multigravida

9
20

29%
65%

2
9

18%
82%

5
9

33%
60%

6
20

22%
74%

Mode of Conception
Natural
Assisted

23
8

74%
26%

4
7

64%
36%

12
3

80%
20%

4
7

64%
36%

*Data missing for 2 participants from Baylor clinics
**All p-values > 0.05 for comparison of UTHealth and Baylor demographics
***All p-values > 0.05 for comparison of interview and survey only demographics
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Attitude toward prenatal genetic screening and testing
Multiple attitudes toward screening and testing were identified. Women carrying twin
pregnancies were found to be significantly more likely to be “in favor of” or “strongly in
favor of” prenatal genetic screening compared to prenatal diagnostic testing (p = 0.049),
(Figure 1).
25

p = 0.049
n=20
(48%)

20
n=13
(31%)

15
n=11
(26%)

10

Screening

n=9
(21%)
n=6
(14%)

5
n=0
(0%)

n=15
(36%)

Diagnostic Testing
n=5
(12%)

n=4
(10%)

n=1
(2%)

0
strongly
against

against

neutral in favor of strongly in
favor of

Figure 1. Attitudes toward screening vs. diagnostic testing

Comparing attitudes of those with a natural conception to those with assisted
conception revealed no significant difference between the groups (p > 0.05). In general, both
groups were more in favor of screening than diagnostic testing, with 80% of those with a
natural conception and 92% of those with assisted conception feeling “in favor of” or
“strongly in favor of” prenatal genetic screening. Indication for genetic counseling referral
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was not found to have a significant influence on attitude toward prenatal genetic screening or
testing (p > 0.05 across indications).
Interest in prenatal genetic screening and/or testing
Interview respondents reported an overall general interest in prenatal genetic
screening and/or testing. Motivations for this interest varied among responses, with the risk
of possible abnormalities in the pregnancy being the most commonly used code. One woman
indicated “[she’s] always scared that [the test] will come back that [they’re] carriers of
something or [their] risk is higher for something” but that “it’s always better to know”.
The next most common motivation for interest in prenatal genetic testing was a desire
for answers in order to be better prepared, reassured, or have peace of mind. Forty-eight
percent of participants selected gaining reassurance about the pregnancy as an influencing
factor in the questionnaire. Participants felt that “it’s one of those things where [they] would
like to be prepared if something was to happen” and that “with twins… [they] need to know
what’s going on as much as possible”. Additional examples of interest in prenatal genetic
screening and/or testing can be found in Table II.
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Table II. Interest in prenatal genetic screening and/or testing
Themes
Responses
Concern for Possible
“… like any other woman I was scared that...something
Abnormalities (n=19)
would be found “
“I’m a little bit more worried about having children after
the age of 34... because of seeing that scale and those
percentages of…the baby being affected with the
different types of chromosome [conditions]”
Wanting Answers (n=9)

“… is there a way for us to find out if we’re going to
have a healthy baby or if both babies are going to be
healthy? Then we want to go ahead and do a
prescreening.“

Preparation (n=7)

“I think it’s important to know everything you can before
going into it”

Reassurance (n=6)

“I would have done it anyways just to kind of make sure
there weren’t any problems
“I just wanted to make sure there wasn’t anything that I
need to be worried about as far as like you know the
health of the baby”

Peace of Mind (n=3)

“[genetic testing] does have such an ability to bring peace
of mind or to… help parents…plan… get a better idea of
what…they’re walking into”
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Concerns about prenatal genetic screening and/or testing
Respondents also expressed concerns about prenatal genetic screening and/or testing.
In some cases, these concerns were strong enough to make the woman not interested in
screening or testing. The most common concern was for the risks posed to the pregnancy as
one woman expressed in her statement “I would’ve rather not taken that risk of losing them
than trying to figure out if something was wrong with them”. An interview with a woman
who conceived via IVF revealed substantial concern about invasive testing due to associated
risks. She said that she felt she “worried more about loss… than if [conception] had
happened easily” and that she knew “it’s not going to be easy… if [they] needed to start
over”. Additional concerns included cost, anxiety, uncertainty, and accuracy of screening
(Table III).
Overall, codes associated with concern about prenatal genetic screening and/or testing
were used more frequently (n = 171) than codes associated with interest in prenatal genetic
screening and/or testing (n = 99).
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Table III. Concerns about prenatal genetic screening and/or testing
Themes
Responses
Risks to Pregnancy (n=19)
“… invasive stuff comes with risks…I definitely didn’t
really want to do those unless there was…a high, high
risk of some abnormalities“
“… but as far as the other options, [FTS] felt like safer,
like a safer option”
“I would’ve rather not taken that risk on losing them then
trying to figure out if something was wrong with them”
Cost (n=16)

“… with the cost involved, I wouldn’t have done it even
for one [baby]”
“I had some friends say no don’t do it it’s kind of a waste
of money.”
“But it wasn’t covered by my insurance and I’m already
paying a lot”
“If money wasn’t something that was obviously sitting
there staring me right in the face… we would have
absolutely gone ahead with the genetic testing.”

Fear and Anxiety (n=18)

“I had a lot of anxiety about the pregnancy as it is…
testing is… another thing to be anxious about.”
”I was actually pretty scared and nervous.“

Uncertainty (n=9)

“I think with fraternal, I’d always wonder… which twin it
came from and…worry about it that way”
“… we didn’t know really what the sort of accuracy rates
were… or many of the specifics of… how the
information, how the results are delivered”

Concern about Accuracy
(n=10)

“… it sounds like the accuracy is higher with just one
baby than it is with two. So I think then we might have
been more willing to do it”
“…if there was only one we might have been more open
to it but since there was two… and the accuracy is not as
high, we were less inclined”
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Factors influencing decision-making
Respondents indicated that information gathering was an important factor in decisionmaking (n = 46) both from information they learned in the genetic counseling session and
outside of the session. For example, one woman said that “if anything, [the genetic
counselor] gave [them] information to actually formulate opinions.”
Experiences in previous pregnancies and experiences of friends and family members
were cited as influencing factors (n = 37). One woman said, “it’s one of those things…
[they’ve] historically done just the… standard first trimester screen”. Additionally,
input of support persons such as partners or spouses played a role in women’s decisionmaking. One woman said that she and her husband “weighed out the pros and cons” and that
he was a “major factor in it… and helped decide if [they] were going to do it or not”. Two of
the most common factors selected in the questionnaire as having influenced participant’s
decisions included being pregnant with twins (48%) and their partner/spouse (43%).
Additional examples of factors influencing decision-making can be found in Table IV.
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Table IV. Factors influencing decision-making
Themes
Responses
Information Gathering (n=46)

“… they just wanted to let me be aware of… there’s a
99% chance, sure that there is nothing wrong with them”
“I felt more aware, I got more… information I guess. I
got more aware of what possibilities of what could be
happening”
“I would say that the only thing that the counselor kind of
affected for was like looking at those charts and seeing…
the percentage of risk based on the age”
“… she broke everything down, you know, and
explained… all of our options”

Prior Experience and
Knowledge (n=37)

“… the test that we chose and doing that with my last
son, him being perfectly fine then I was pretty much at
ease with doing the same test”
“… my cousin got the [amniocentesis]… she wanted to
know and she ended up losing her kids cause of the
infection”
“I was seen by the same doctor with… all my three
children… But I was never offered… so I didn’t even
know you had those kind of testing”

Support Persons (n = 2)

“… my husband. I asked him what he thought and he said
yeah let’s just do the same test we did with my son”
“… my mom… went with me… she was the one who…
guided me in the decision making process.”
“… my mom said that she never got any of that testing
done but I just don’t think it was available at the time. I
don’t know what she would have done now.”
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Uptake of prenatal genetic screening and testing
There was no significant difference in uptake of prenatal genetic screening and testing
between natural and assisted conception women (p = 0.48). When asked about whether or not
their decision about prenatal genetic screening or testing agreed with their feelings prior to
the genetic counseling appointment, 91% answered that it did agree. Additionally, 86% of
women answered that their decision about prenatal genetic screening and testing would have
been the same if it were a singleton pregnancy. Of the 41 women offered a prenatal genetic
screening or diagnostic test, 39% declined all testing. Of the 36 women offered prenatal
genetic screening (first trimester screen, quadruple screen, NIPT), 69% accepted. Of the 39
women offered diagnostic genetic testing (chorionic villus sampling, amniocentesis), one
individual accepted (Figure 2).

36 offered
genetic
screening

25 accepted
(69%)
11 declined
(31%)

41 offered
39 offered
diagnostic
testing

1 accepted (3%)
38 declined
(97%)

Figure 2. Uptake Flowchart

Individuals who accepted a screening test had attitudes that were generally more
“strongly in favor of” screening (56%) compared to those that declined screening tests
(18%); however, the overall difference in attitudes was not significant (p = 0.053). Those
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who accepted a prenatal genetic screening test were significantly more likely to say that they
would make the same decision if it were a singleton pregnancy (p = 0.030), (Figure 3). All
four of the women who indicated that they would make a different decision about prenatal
genetic screening or testing in the pregnancy if it were a singleton were also a part of the
48% of women who selected being pregnant with twins as having influenced decisions.
100
90

n=23
(92%)

80

p = 0.030

n=7
(64%)

70
60
50

Yes uptake

40

No uptake

30
20

n=2
(8%)

10

n=2
(18%)

0
Same

Different

n=2
(18%)
n=0
(0%)
I don’t know

Figure 3. Influence of twin pregnancy on screening uptake

DISCUSSION
To our knowledge, this is the first study exploring the attitudes toward and uptake of
prenatal genetic screening and testing in twin gestations since the advent of NIPT. As
anticipated from increasing trends toward screening in singleton pregnancies since the
introduction of NIPT, we found that women carrying twins were more likely to be in favor of
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prenatal genetic screening compared to diagnostic testing (13). The risk of diagnostic testing
appeared to be a deterrent for some, as seen in previous studies (14). Women communicated
a desire to have answers to be better prepared or for reassurance. Attitudes did not differ
depending on whether women conceived twin pregnancies naturally or through assisted
conception methods. Despite participants being in favor of screening, concerns and barriers
were more frequently discussed than interest. In these cases, genetic counseling was used as a
platform to relay these concerns and gather additional information about screening and
testing, empowering women to make a decision. It appears as though the genetic counseling
process made women feel more comfortable with their decision rather than altering it,
although future research is needed to capture both pre and post counseling feelings in order
to confirm this finding.
Our cohort did elect to undergo screening or testing more often (61%) than a 2006 cohort
of 343 twin or higher or multiple pregnancies (23%), (11). It is possible that this difference
can be explained by the availability of NIPT, since the higher detection rate and lower false
positive rate compared to older screens may have lessened concerns. Given that detection
rates are even higher in singletons, those who elected to undergo screening might have done
so regardless of twin gestation.
The majority of women said they would make the same decision if they had a singleton
pregnancy, suggesting that having twins was not an influencing factor. This finding is
contradictory to the finding that “being pregnant with twins” was the most commonly cited
factor in interviews influencing their decision-making. Perhaps those that did not uptake any
screening or testing were more influenced by twin pregnancy. In fact, the women who
indicated that they would make a different decision about prenatal genetic screening or
17

testing in the pregnancy if it were a singleton were a part of the 48% of women who selected
being pregnant with twins as having influenced decisions. They may have recognized an
additional layer of complexity involved in screening and testing for twins. Genetic
counselors have the skill set to uncover which women are concerned about this complexity,
encourage discussion, and assist in decision-making.
The process of genetic counseling did not appear to ultimately change decisions about
prenatal genetic screening and testing for most women, although interview responses
indicated that patients do find it helpful and informative. Information gathering about genetic
screening and testing takes place in multiple settings, including medical appointments, past
personal experience, and the experiences of family and friends. It is possible that anchoring,
the concept that people’s decisions are most influenced by their initial experiences and
knowledge, can explain the why the majority of women reported that genetic counseling did
not change their initial impression of genetic screening and testing (15). The anchoring
heuristic has been previously explored in genetic counseling decision-making, with positive
attitude towards genetic testing being one of the determining factors predicting intent to
undergo testing (16). While patients say they are open to learning more information, anchors
appear to play an important role in prenatal genetic counseling.
Practice Implications
This study provides insight into the attitudes toward prenatal genetic screening and
testing in women carrying twin pregnancies in an effort to assist in the tailoring of sessions
for this patient population. Data suggest that tailoring sessions for twin gestations might
parallel that of singletons. Anticipating concerns about risks, cost, uncertainty, and
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accuracy surrounding testing options might make facilitation of decision-making easier
and uncover those patients for whom the complexity alters their decision. However, it is
not likely to change the majority of patient’s attitudes set by personal anchors.
Study Limitations
The small sample size was a major limitation of the current study, as this impacted
the ability to make comparisons between those with natural and assisted conceptions in the
interview portion. A longer recruitment time frame might increase sample size enough to
achieve statistical significance. Another limitation was the limited demographic information
collected, as the influence of socioeconomic status, education level, or religious affiliation on
decision-making could not be explored.
Of note, the interviews did not take place at the same duration after the genetic
counseling appointment for all participants. Some individuals could not be reached for over a
month, and it is possible that the length of time since the genetic counseling appointment
altered their attitude and responses. In addition, participants who had stronger attitudes
toward prenatal genetic screening and testing may have felt compelled to share their
perspectives and thus led to an ascertainment bias.
Future Directions
Additional studies with larger cohorts should be undertaken in order to determine if
there are in fact differences between the natural and assisted conception groups on qualitative
section of the questionnaire. In addition, including a singleton matched comparison group
could provide more insight into potential differences.
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CONCLUSION
The majority of women with twin gestations were in favor of and opted into prenatal
genetic screening, despite expressing concerns. Most did not feel that their decision would
vary if they had been carrying a singleton, suggesting that tailoring genetic counseling for
twin gestations might be similar to that of singletons. Genetic counselors have the skill set
to uncover which women belong to the minority who are concerned about the complexity of
screening in twins and to assist in decision-making.
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APPENDIX A.
1.

How do you feel about prenatal genetic screening (first trimester screening, quad screening, NIPT,
cell-free DNA) in your current pregnancy?
Strongly against
1

2.

4.

5.

3

Strongly in favor of
4

5

How do you feel about prenatal genetic testing (chorionic villus sampling-CVS, amniocentesis) in your
current pregnancy?
Strongly against
1

3.

2

2

3

Strongly in favor of
4

5

Does your decision to undergo or not undergo prenatal genetic screening/testing agree with your
feelings prior to the genetic counseling appointment?
Yes
No
Additional comments:_______________
If this were a singleton pregnancy, what would your decision about prenatal genetic screening/ testing
have been?
Same
Different
If different, in what way?:______________
I don’t know
What factors influenced your decision-making? Choose all that apply:
£ Partner/Spouse
£ Gaining reassurance about pregnancy
£ Other family member
£ Screening/testing in prior pregnancy
£ Doctor
£ Being pregnant with twins
£ Genetic Counselor
£ Difficulty becoming pregnant
£ Religious beliefs
£ I don’t know
£ Risk for pregnancy loss
£ None of the above
£ Chance of chromosome
£ Other:________________
condition
£ Cost

___________________________________________________________________________
For Office Use Only:
Date:___________
Age:______

G_____P_____

Ethnicity:

Caucasian Hispanic
Asian African American
Other:___________

ART?: IVF IUI OI/Clomid
PGS PGD Donor egg: Y/N
Other:_______________

Offered Screens/Tests: FTS Quad NIPT
CVS Amnio
Accepted Screens/Tests: FTS Quad NIPT
CVS Amnio
Indication:
Low Risk
AMA
Positive FTS
Positive Quad Screen
Positive Family History
Positive Carrier Screen
Ultrasound Abnormality
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APPENDIX B.
Interview Guide
Questions:
• Tell me about your experience getting pregnant.
o Probes
§ What was your reaction to learning that you were pregnant with twins?
§ Was this a positive or difficult experience?
§ How did it affect your family and relationships?
• Tell me about your experience with genetic counseling.
o Probes
§ What were your feelings toward/impressions of prenatal genetic
screening and testing before the session?
• Concerns?
§ Did any prior feelings change after talking to the genetic counselor?
• How? Why?
§ Had you heard of prenatal genetic screening or testing prior to the
appointment?
• Did you pursue this option in a prior pregnancy?
• Tell me about how you came to a decision about prenatal screening or testing.
o Probes
§ Do you think you would have felt the same way and made the same
decision if this were a singleton pregnancy?
§ Why did you choose______ over other options offered?
§ What factors influenced your decision?
§ Other than yourself, who played an important role in your decision?
• Is there any other information you would like to share about carrying twins, having
genetic counseling, screening or testing?
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